Aneuploidy as a promoter and suppressor of malignant growth

A Vasudevan, KM Schukken, EL Sausville… - Nature Reviews …, 2021 - nature.com
Aneuploidy has been recognized as a hallmark of tumorigenesis for more than 100 years,
but the connection between chromosomal errors and malignant growth has remained …

[HTML][HTML] The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells

PW Andrews, I Barbaric, N Benvenisty, JS Draper… - Cell Stem Cell, 2022 - cell.com
It is well established that human pluripotent stem cells (hPSCs) can acquire genetic and
epigenetic changes during culture in vitro. Given the increasing use of hPSCs in research …

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

AS Lee, C Tang, MS Rao, IL Weissman, JC Wu - Nature medicine, 2013 - nature.com
Human pluripotent stem cells (PSCs) are a leading candidate for cell-based therapies
because of their capacity for unlimited self renewal and pluripotent differentiation. These …

Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics

KG Chen, BS Mallon, RDG McKay, PG Robey - Cell stem cell, 2014 - cell.com
Human pluripotent stem cells (hPSCs) provide powerful resources for application in
regenerative medicine and pharmaceutical development. In the past decade, various …

Induced pluripotency: history, mechanisms, and applications

M Stadtfeld, K Hochedlinger - Genes & development, 2010 - genesdev.cshlp.org
The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated
that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced …

ISSCR standards for the use of human stem cells in basic research

TE Ludwig, PW Andrews, I Barbaric, N Benvenisty… - Stem cell reports, 2023 - cell.com
The laboratory culture of human stem cells seeks to capture a cellular state as an in vitro
surrogate of a biological system. For the results and outputs from this research to be …

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

T Aasen, A Raya, MJ Barrero, E Garreta… - Nature …, 2008 - nature.com
The utility of induced pluripotent stem (iPS) cells for investigating the molecular logic of
pluripotency and for eventual clinical application is limited by the low efficiency of current …

Genetic and epigenetic variations in iPSCs: potential causes and implications for application

G Liang, Y Zhang - Cell stem cell, 2013 - cell.com
The ability to reprogram somatic cells to induced pluripotent stem cells (iPSCs) has
revolutionized the field of regenerative medicine. However, recent studies on the genetic …

[HTML][HTML] Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

LC Laurent, I Ulitsky, I Slavin, H Tran, A Schork… - Cell stem cell, 2011 - cell.com
Genomic stability is critical for the clinical use of human embryonic and induced pluripotent
stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on …

A scalable system for production of functional pancreatic progenitors from human embryonic stem cells

TC Schulz, HY Young, AD Agulnick, MJ Babin… - PloS one, 2012 - journals.plos.org
Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will
require the translation of proof-of-principle concepts into a scalable, controlled, and …